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Streptococcus pneumoniae is the major cause of bacterial pneumonia, and it is also responsible for otitis me-
dia and meningitis in children. Apart from the capsule, the virulence factors of this pathogen are not com-
pletely understood. Recent technical advances in the field of bacterial pathogenesis (in vivo expression
technology and signature-tagged mutagenesis [STM]) have allowed a large-scale identification of virulence
genes. We have adapted to S. pneumoniae the STM technique, originally used for the discovery of Salmonella
genes involved in pathogenicity. A library of pneumococcal chromosomal fragments (400 to 600 bp) was con-
structed in a suicide plasmid vector carrying unique DNA sequence tags and a chloramphenicol resistance
marker. The recent clinical isolate G54 was transformed with this library. Chloramphenicol-resistant mutants
were obtained by homologous recombination, resulting in genes inactivated by insertion of the suicide vector
carrying a unique tag. In a mouse pneumonia model, 1.250 candidate clones were screened; 200 of these were
not recovered from the lungs were therefore considered virulence-attenuated mutants. The regions flanking the
chloramphenicol gene of the attenuated mutants were amplified by inverse PCR and sequenced. The sequence
analysis showed that the 200 mutants had insertions in 126 different genes that could be grouped in six classes:
(i) known pneumococcal virulence genes; (ii) genes involved in metabolic pathways; (iii) genes encoding
proteases; (iv) genes coding for ATP binding cassette transporters; (v) genes encoding proteins involved in
DNA recombination/repair; and (vi) DNA sequences that showed similarity to hypothetical genes with un-
known function. To evaluate the virulence attenuation for each mutant, all 126 clones were individually
analyzed in a mouse septicemia model. Not all mutants selected in the pneumonia model were confirmed in
septicemia, thus indicating the existence of virulence factors specific for pneumonia.
Streptococcus pneumoniae is the major cause of community-
acquired bacterial pneumonia, and it is also responsible for
otitis media and meningitis (2). Capsular polysaccharides
were the first virulence factors to be identified. The capsule
is thought to protect the bacteria from the host immune system
by preventing phagocytosis (17). Purified capsular extracts do
not have an inflammatory or toxic effect (31, 32). Among the
proteins considered to be virulence factors (17, 45) are pneu-
molysin (3, 7, 12), autolysin (4, 12, 56), hyaluronidase (5),
pneumococcal surface protein A (PspA) (8), PsaA (6), neur-
aminidase (10), immunoglobulin A1 (IgA1) protease (46, 59),
and pyruvate oxidase (55), although for some of them a role in
virulence has not been demonstrated.
Recent advances in the field of bacterial pathogenesis have
allowed a large-scale identification of new virulence genes in
different bacterial species. The methods developed are based
on the concept that specific gene products are required for
each stage of an infection process and that their expression is
often regulated by the different environmental conditions en-
countered in the host. Mahan et al. (38) developed a system
called IVET (in vivo expression technology) aimed at identi-
fying bacterial genes that were preferentially expressed in the
host during infection and were poorly transcribed under labo-
ratory conditions. IVET was originally developed for use with
Salmonella typhimurium (38) and then applied to Vibrio chol-
erae (11) and Pseudomonas aeruginosa (58). Hensel et al. (28)
expanded the concept of tagging originally developed by Walsh
and Cepko (57) to monitor the fate of clonally related neocor-
tical cells during brain development, developing a strategy to
identify virulence genes by negative selection. This system,
called STM (signature-tagged mutagenesis), exploits a pool of
transposons in which each transposon is tagged with a unique
DNA sequence so that the resulting insertion mutants are
marked with a different DNA sequence. This permits the iden-
tification of bacteria recovered from hosts infected with a
mixed population of mutants.
Tagged insertion mutants are combined into pools, which
are used to infect the animals. At a defined time point, bacteria
are recovered from the animals. Tag sequences are amplified
from each pool by using a radioactive label before and after the
infection. These two labeled tag probes are hybridized to filters
containing spotted genomic DNA from all mutants of the cor-
responding pool. Mutants whose tags are positive for hybrid-
ization with the probe from the original pool and negative with
the one from the recovered bacteria are considered to be vir-
ulence attenuated. This system was originally used to identify
genes involved in virulence in S. typhimurium (28) and recently
applied to Staphylococcus aureus and V. cholerae (15, 42).
S. pneumoniae has been studied for many years, yet its vir-
ulence mechanisms are not fully understood (17). Therefore,
we have modified the original STM methodology to discover
novel virulence factors in S. pneumoniae. Initially, we attempt-
ed to use for this purpose the encapsulated type 3 strain
GP119, obtained by transformation from the nonencapsulated
avirulent laboratory strain Rx1. Surprisingly, when GP119 was
tested for virulence in a mouse septicemia model, it was found
to be not virulent (unpublished observations); this result indi-
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cates that in factors in addition to the capsule are required for
virulence. We then selected the encapsulated type 19F strain
G54, a recent clinical isolate. This strain was chosen because of
its high transformation rate (47) induced by using the 17-resi-
due competence-stimulating peptide (26) and its virulence in a
mouse pneumonia model, as assessed in our laboratory. The
following two major changes were introduced in the original
STM protocol (28).
(i) A library of tagged mutants was constructed by insertion-
duplication mutagenesis using short random genomic DNA
fragments inserted in a suicide plasmid vector bearing the
molecular tag. The original transposon mutagenesis technique
(28) was not applied to S. pneumoniae, since we did not expect
transposons to insert randomly as shown for Streptococcus mu-
tans (24) and Lactococcus lactis (49).
(ii) While in the original method (28) the filters correspond-
ing to each pool had spots of genomic DNA from each mutant
obtained by transferring bacterial colonies to the filters (colony
hybridization), we used filters containing amplified tags from
each mutant. This modification was necessary since in our
hands colony hybridization generated a high background giving
rise to false positives.
Using the modified STM technique, we identified 126 puta-
tive virulence genes from S. pneumoniae. Some of them
corresponded to previously described pneumococcal viru-
lence factors, while others showed homology to virulence
genes found in other bacteria. In addition, we have identified
genes not previously known to be involved in virulence.
MATERIALS AND METHODS
Media. Escherichia coli strains were grown in Luria broth (LB; Difco). S. pneu-
moniae strains were grown in Todd-Hewitt broth (Difco), and tryptic soy broth
(TSB; GIBCO) or agar plates. When needed, these media were supplemented
with ampicillin (100 mg/ml), chloramphenicol (8 mg/ml), or 5% defibrinated
sheep blood (Unipath; Oxoid).
Animals. Male BALB/c mice weighing 16 to 18 g (Charles River, Como, Italy)
were used.
Competence factor 1. The 17-amino-acid peptide used to stimulate compe-
tence was synthesized by Neosystem Laboratoire (Strasbourg, France) according
to the published sequence (26).
Construction of the tagged library. A pool of single-stranded 89-bp DNA
molecules containing a central stretch of 40 random bp flanked by two constant
sequences was generated by oligonucleotide synthesis. The constant regions
contained HindIII and KpnI sites (Fig. 1). The sequence of the random 89-mer
oligonucleotides used was 59-CTAGGTACCTACAACCTCAAGCTTN40AAG
CTTGGTTAGAATGGGTACCATG-39. The constant regions allowed the se-
quence tags to be amplified by PCR using the upper primer (59-TACCTACAA
CCTCAAGCT-39) and the lower primer (59-TACCCATTCTAACCAAGC-39).
The double-stranded library of tags was generated by extending the 18-mer
primer P1 (59-CATGGTACCCATTCTAAC-39) annealed to the random 89-mer
template. Ten micrograms of P1 primer was mixed with 3 mg of 89-mer random
template in 14 ml of annealing buffer (T7 sequencing kit; Pharmacia) and an-
nealed as indicated by the manufacturer. T7 DNA polymerase (8 U) and 3 ml of
5 mM deoxynucleoside triphosphates (dNTPs) were added and incubated for 30
min at 37°C. The final population of double-stranded DNA molecules was
digested with KpnI. The corresponding DNA band was recovered from a 7%
polyacrylamide gel, subcloned into the KpnI site of pR326 vector (3 mg) (16)
(Fig. 1), and used to transform E. coli DH5a by electroporation with a Bio-Rad
apparatus according to the manufacturer’s instructions. Ten electrotransforma-
tion preparations, each containing 100 ml of cells and approximately 300 ng of
vector DNA, were pooled, and a small aliquot was plated to assess transforma-
tion efficiency. The remainder was added to 500 ml of LB with ampicillin and
grown for 8 h with shaking. Tagged DNA plasmids (tagged library) were then
extracted and stored at 220°C.
Tagged genomic library construction. S. pneumoniae chromosomal DNA was
isolated from G54 (47) as reported by Dillard and Yother (19).
Chromosomal DNA (40 mg) was sheared with a French cell press (SLM
Aminco) as indicated by the manufacturer. The DNA ends were repaired by
using 25 U of Klenow polymerase, 15 U of T4 DNA polymerase, and 50 mM
dNTPs. The blunt-ended DNA was then size fractionated by centrifugation in a
10 to 40% sucrose gradient (26,000 rpm for 18 h in an SW28 rotor (Beckman)
(2a). The size of each fragment from the fractions was determined by agarose gel
electrophoresis. Fractions from 400 to 600 bp were pooled, dialyzed, and ethanol
precipitated. The fractions were resuspended in 200 ml of 13 ligase buffer and
ligated for 16 h at 4°C with 20 mg of BamHI phosphorylated linkers (New
England Biolabs) and 1,000 U of T4 DNA ligase. This mixture was then digested
with BamHI and ligated to the BamHI-digested tagged plasmid library (Fig. 1).
The ligation mixture was used directly to transform S. pneumoniae G54 as
reported by Pozzi et al. (47). The bacteria were plated on tryptic soy agar plates
containing 8 mg of chloramphenicol per ml and incubated for 16 h at 37°C and
5% CO2. The multilayer plating technique described by Pozzi et al. (47) was used
to ensure that each chloramphenicol-resistant (Cmr) colony had arisen from one
independent recombinational event.
The colonies were picked, inoculated in TSB containing 8 mg of chloramphen-
icol per ml, grown to an OD600 (optical density at 600 nm) of 0.6, and frozen
individually with glycerol (10%, final concentration). Preparation of the pools
was performed as follows: 50 mutants were individually inoculated in 3 ml of TSB
containing 8 mg of chloramphenicol per ml, and the cells were grown up to OD600
of 0.6; 300 ml of each culture was pooled (in vitro pool) and frozen with 10%
(final concentration) glycerol.
Three hundred microliters of the frozen in vitro pool was inoculated into 3 ml
of TSB containing 8 mg of chloramphenicol per ml, and the cells were grown up
to OD600 of 0.9, corresponding to a concentration of 109 cells/ml. An aliquot was
removed for DNA extraction, while 50 ml of the remaining culture was used to
inoculate the mice as described below.
Filter preparation. The individual DNA tag from each mutant was amplified
by PCR as follows. The mutants were grown in 3 ml of TSB containing 8 mg of
chloramphenicol per ml to an OD600 of 0.6; 1 ml of this culture was centrifuged,
the bacterial pellet was resuspended in 100 ml of H2O and then heated at 96°C
for 5 min; 4 ml of lysate was used as the template. The PCR mixture (50 ml)
contained the primers (1 mM each), dATP, dTTP, dGTP, and dCTP (0.2 mM
each), 4 ml of DNA solution, Taq DNA polymerase (1 U), and 5 ml of Taq
polymerase 103 buffer (Perkin-Elmer Cetus). Twenty cycles of denaturation (60
s at 94°C), annealing (60 s at 50°C), and polymerization (10 s at 72°C) were
performed on a Perkin-Elmer Cetus thermocycler. The amplification products
were checked on a gel, and the same amount of DNA tags was spotted onto
duplicate filters.
Pneumonia and septicemia animal models. The animal model developed by
Canvin et al. (12) was adapted for this work. The experiments were carried out
in accordance with prevailing legislation (Decreto legislativo italiano no. 116),
company policy on the care of use of animals, and related codes of practice.
Enflurane (Abbott)-anesthetized mice were intranasally inoculated with 50 ml
(;108 CFU) of a Todd-Hewitt broth suspension of a pool of mutants S. pneu-
moniae. Groups of six BALB/c mice were randomly assigned to each treatment.
After 32 h of infection, the mice were sacrificed by cervical dislocation and their
lungs were aseptically removed. The lungs from a single animal were washed free
of blood and homogenized in sterile Potter homogenizers in 10 ml of sterile
phosphate-buffered saline. The number of CFU in the supernatant (in vivo pool)
was determined by serial dilution and plating in triplicate on 5% blood agar
plates supplemented with chloramphenicol (8 mg/ml).
Septicemia experiments were performed as follows. Each clone was grown in
TSB to an OD600 of 0.2. The bacterial culture was serially diluted and each
dilution was plated for counting the viable cells. Dilutions of 105, 104, and 103
CFU/ml were mixed with an equal volume of 8% (wt/vol) hog mucin, and 500 ml
of each dilution was then injected intraperitoneally into five BALB/c mice. The
infected mice were monitored over 4 days; each day the surviving mice were
counted, and the results were compared to those for the control strains G54 and
pR212 (avirulent noncapsulated G54; received from G. Pozzi).
Probe preparation and hybridization. Five-microgram aliquots of chromo-
somal DNA extracted from S. pneumoniae in vitro and in vivo pools (19) were
used as PCR templates to generate labeled probes. Genomic DNA was amplified
by PCR as described above. The amplified DNA was separated on a 3% low-
melting-point agarose gel, and DNA bands of approximately 80 bp were recov-
ered. Then 5 ml of melted agarose was used as a template for a second PCR to
generate the labeled probes. The PCR mixture (30 ml) contained primers (1 mM
each), dATP, dTTP, and dGTP (0.2 mM each), 0.05 mM dCTP, 5 ml of
[32P]dCTP (5,000 mCi/mmol), Taq DNA polymerase (1 U), and 3 ml of Taq
polymerase 103 buffer (Perkin-Elmer Cetus). Twenty cycles of denaturation (30
s at 92°C), annealing (60 s at 50°C), and polymerization (10 s at 72°C) were
performed. The amplified DNA was digested with HindIII; the 40-bp fragment
was recovered from a 6% low-melting-point agarose gel and added to 5 ml of
hybridization buffer (53 SSC [13 SSC is 0.15 M NaCl plus 0.015 M sodium
citrate], 2% blocking reagent [Boehringer], 0.02% sodium dodecyl sulfate). The
filters were hybridized for 14 h at 50°C in a Hybaid hybridization oven range,
washed twice in washing buffer (53 SSC, 0.02 sodium dodecyl sulfate) for 30 min
at 42, 50, and 55°C, dried, and autoradiographed with Kodak XAR-5 film at
280°C for 24 to 72 h.
Southern blot analysis. Southern blot experiments and 32P DNA probe label-
ing were performed according to standard methods (54).
Localization of the integration site in the virulence-attenuated mutants. In-
verse PCR was used to amplify the genomic DNA segment flanking the chlor-
amphenicol resistance (cat) gene in the S. pneumoniae mutants. Two micrograms
of genomic DNA was digested separately with each of the enzymes KpnI, HincII,
ClaI, and HindIII for 8 h at 37°C. Digested genomic DNA was diluted 100-fold
and self-ligated. One microliter of ligation mixture was used as a template for
PCR using primers cat0 (59-ACAGCTTCCAGATCCATATCC-39) and cat770
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(59-TATCCCACTTTATCCAATTTT-39) (Fig. 1). The PCR mixture (50 ml)
contained primers (1 mM each), dATP, dTTP, dGTP, and dCTP (0.2 mM each),
Taq DNA polymerase (1 U), and 5 ml of Taq polymerase 103 buffer (Perkin-
Elmer Cetus). Twenty cycles of denaturation (30 s at 92°C), annealing (60 s at
50°C), and polymerization (1.5 min at 72°C) were performed. One microliter of
the PCR reaction was used as the template in a nested reaction performed under
the same conditions as described above, using primers cat1 (59-TGACGTTGA
GCCTCGGAACCCATCG-39) and cat720 (59-GTTGAACCATTATATCACA
TT-39) (Fig. 1). The average size of the amplified DNA product was 500 bp. The
PCR products were sequenced with an automated sequencer (ABI Prism 377) as
instructed by the manufacturer. Predicted amino acid sequences from all six
reading frames of the DNA sequences obtained above were subjected to simi-
larity search of the SWISS-PROT TREMBL database, using the BLAST pro-
grams (1).
RESULTS
Construction of a tagged S. pneumoniae chromosomal DNA
library. The pR326 vector (16) is unable to replicate in S. pneu-
moniae and carries two markers: one for ampicillin resistance
and the other for chloramphenicol resistance (cat). The latter
is under the control of the pneumococcal promoter amiA and
therefore can be expressed in S. pneumoniae. A mixture of
double-stranded DNA tags was ligated into plasmid pR326.
The ligation mixture was used to transform E. coli DH5a to
obtain a pool of pR326 plasmid DNA tags (Fig. 1A). The
central variable sequence allows the potential generation of
1017 different tags. Thirty ampicillin-resistant colonies were
picked at random, and the variable 40-bp region of the tag was
sequenced by using both upper and lower primers. None of the
30 plasmids tested contained identical 40-bp sequences (data
not shown). The tagged genomic library was constructed by
cloning fragments of S. pneumoniae chromosomal DNA from
the G54 strain in the pool of tagged plasmids (Fig. 1). There-
fore each fragment was associated with a unique DNA se-
quence tag. The G54 strain was transformed with this tagged
genomic library. Since pR326 cannot replicate in S. pneumo-
niae, Cmr colonies could be generated only by integration of
the donor vector at the region of the chromosome which was
homologous to the pneumococcal DNA fragment inserted in
the vector (Fig. 1B). Using this procedure, we selected 1,250
Cmr mutants.
The DNA tag from each mutant was amplified by PCR;
equal amounts of all DNA tags were spotted on duplicate
filters. To verify that the Cmr clones resulted from random
homologous insertion of a single tagged plasmid, Southern blot
analysis was performed. The chromosomal DNA was extracted
from four clones and then subjected to a single digestion with
EcoRV (which is absent from pR326) and to a double diges-
tion with EcoRV and NcoI (which cuts once in the cat gene
[Fig. 1]). The cat gene from pR326 was used as a probe. The
results showed that each mutant had arisen from a single
integration of the plasmid into a random site of the bacterial
genome (Fig. 2).
Screening for virulence genes. The mutant library was ana-
lyzed for reduced virulence in a mouse pneumonia model sys-
tem (12). The 1,250 mutants were grouped in 25 pools of 50
clones; for each pool, duplicate filters containing spots of the
individually amplified tags were prepared. The pooled mutants
were grown in liquid medium, an aliquot was then removed,
and genomic DNA was extracted; this represented the inocu-
lated in vitro pool (Fig. 3). The bacteria were inoculated in
mice intranasally, and six animals were used for each pool.
After 32 h, the mice were killed and the lungs were recovered;
then the bacteria were titrated and cultured in liquid medium.
The bacteria recovered (approximately 105 from each mouse)
were pooled, and the DNA was extracted; this represented the
recovered in vivo pool (Fig. 3). The tags from the in vitro and
the in vivo pools were amplified by PCR using 32P label in the
reaction. The invariant arms of 20 bp were released by diges-
tion with HindIII (Fig. 1), and the radiolabeled 40-bp central
sequences were used as a probe against the duplicate filters.
Figure 4 shows as an example two filters hybridized with the in
vivo and in vitro tags; tags that hybridize to the probe from the
inoculated in vitro pool but not to the probe from the recov-
ered in vivo pool represent mutants with attenuated virulence.
From the screen of our 1,250 S. pneumoniae mutants, we iden-
tified 200 clones whose tag did not hybridize to the probe ob-
tained from the recovered pools, showing reduced virulence in
vivo.
Sequence analysis of the virulence-attenuated clones. To
identify the genes responsible for virulence attenuation, we
first attempted to clone the DNA regions flanking the cat
insertion point in E. coli either by recovering plasmid pR326 or
by cloning the resistance marker and its flanking region into a
low-copy-number vector. In many cases, the plasmids were not
stable and were severely rearranged. Instability of plasmids
containing streptococcal DNA in E. coli is well documented
(14, 18, 40). To circumvent this problem, the regions flanking
the cat insertion points were identified by inverse nested PCR
and subsequently sequenced as described in Materials and
Methods. Sequence analysis of the 200 clones revealed that
they originated from insertions in 126 different genes. Some of
the mutants resulted from different insertions within the same
gene, whereas in other cases the mutants had identical inser-
tion points within the same gene.
As shown in Table 1, the sequences obtained from the
126 mutants can be grouped in five classes. Only key examples
of each class are discussed below.
The first class comprises insertions in previously identified
S. pneumoniae virulence factors: hyaluronidase (SPN-673), neur-
aminidase (SPN-605), autolysin (SPN-1264), and IgA1 pro-
tease (SPN-1810). One more insertion (SPN-227) was found in
a gene product that belongs to the family of choline binding
proteins (CBPs) since it possesses at the C-terminus the re-
peated signature choline binding domain (52) (Table 1).
The second class includes insertions in genes involved in
metabolic pathways: purine biosynthesis (SPN-1645, SPN-786,
SPN1404, and SPN-2078), phosphate assimilation (SPN-1589),
synthesis of glutamine (SPN-902), and anaerobic metabolism
(SPN-181).
The third class includes an insertion in a gene that show
similarity to ATP-dependent proteases. SPN-1055 maps in an
FIG. 1. (A) Construction of a pool of pR326 plasmid DNA tags. A pool of double-stranded DNA tags was generated by extending with T7 DNA polymerase the
18-mer primer P1 annealed to random 89-mer templates (see Materials and Methods). Each tag is a variable sequence of 40 bp (N40), where N is A, C, G, or T, flanked
by two constant arms of 20 bp which contain restriction sites for HindIII and KpnI. These arms allow PCR amplification with the upper primer (U.P.) and lower primer
(L.P.) of each tag. Tags were digested with KpnI and ligated in the vector pR326, generating a pool of tagged plasmids. (B) Construction of a library of S. pneumo-
niae-tagged mutants by homologous recombination. S. pneumoniae chromosomal DNA was mechanically sheared; fragments ranging from 500 to 700 bp were size
selected and ligated with the pool of pR326 plasmids DNA tags. The ligation mix was directly transformed in S. pneumoniae G54; homologous recombination events
lead to insertion-duplication mutagenesis, with the plasmid carrying the cat gene and the tag inserted into the inactivated gene in the chromosome. Total genomic DNA
was extracted from mutant clones, digested with a restriction endonuclease, and circularized by ligation. The genomic flanking region outside the cat gene was amplified
with the inner set of primers cat0 and cat770; 4 ng of the product of the first PCR was reamplified with the nested pair of primers cat1 and cat720. The resulting
single-PCR product was then sequenced.
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S. pneumoniae gene whose product shows similarity to ClpC,
an ATP-dependent protease whose activity is essential for sur-
vival of Listeria monocytogenes in macrophages (51).
The fourth class includes insertions found in genes coding
for polypeptides that show similarity to the ATP binding cas-
sette (ABC) family of transporters, and all possess the con-
served A and B Walker motifs (29). Two insertions were
mapped in genes similar to potA (SPN-2041) and potD (SPN-
924) belonging to the ABC transport system for spermidine
and putrescine. Glutamine appears to be a key metabolite for
virulence since two mutants were found to have insertions in
genes homologous to glnH and glnQ (SPN-1364 and SPN-
1452), two components of the well-characterized high-affinity
glutamine transport system. Mutant SPN-1802 showed striking
similarity to the MsmK of S. mutans, the ATP binding com-
ponent of an ABC transporter involved in uptake of multiple
sugars (53). SPN-948 showed similarity to the MesD protein
(22), a member of the HlyB subfamily of ABC transporters
involved in the transport of bacteriocins and toxins (20, 29).
The fifth class contains mutants showing insertions in genes
involved in mutation avoidance: recJ and mutX (SPN-1411 and
SPN-1634, respectively). Mutations which impair DNA recom-
bination/repair have already been identified as essential for
survival in macrophages in S. typhimurium (9, 27) and to be
responsible for virulence attenuation in S. aureus (42).
Finally, 63 mutants whose insertions mapped within hypo-
thetical genes with unknown function were identified. Some of
these genes are described in Table 2.
Analysis of septicemia of the virulence-attenuated clones.
To evaluate rapidly the attenuated virulence of the individual
mutants in a different in vivo model, all 126 clones were indi-
vidually analyzed in a mouse septicemia model. The mutants
fell into three classes, as shown in Table 1. Those mutants
showing the same virulence as G54 (intraperitoneal 50% lethal
dose of 102) were classified as high, since all of the 15 treated
mice died within 2 days. Mutants showing the same virulence
attenuation as the nonencapsulated PR212 strain (intraperito-
neal 50% lethal dose of .105) were classified as low, since all
of the 15 treated mice survived the 4-day duration of the
experiment. Mutants falling in between the two classes were
defined as medium. Thirty-six mutants were shown to belong to
the low-virulence class, 52 were classified as having medium
virulence, and 38 were as virulent as the parent strain (G54)
and thus classified as having high virulence. The analyzed mu-
tants had different in vitro growth rates; however, we did not
find a correlation between the loss of virulence and slow-
growing bacteria since several mutants that grew very slowly in
vitro showed the same virulence as G54 wild-type strain. We
conclude that in vivo and in vitro growth rates do not correlate.
FIG. 2. Southern blot analysis of mutants. Genomic DNAs obtained from
clones 23, 187, 985, and 1177 were digested with EcoRV (E), or with EcoRV and
NcoI (E/N). The EcoRV site is absent in pR326; the NcoI site is unique to the
cat gene. Five micrograms of digested DNA was then applied on 0.8% agarose
gel, electrophoresed, blotted on nylon filter, and subjected to Southern hybrid-
ization analysis using the cat gene as a probe. G54 genomic DNA did not
hybridize to the probe (data not shown). The positions of size markers are shown
in kilobases on the right.
FIG. 3. Design of virulence gene screening. S. pneumoniae chromosomal
DNA was fragmented, size selected, and ligated with the pool of pR326 plasmid
DNA tags. Homologous recombination events lead to insertion-duplication mu-
tagenesis. DNA tags were individually amplified from all mutants and applied to
duplicate filters in groups of 50; 50 mutants representing the tags on each filter
were pooled and grown in a flask (20 ml of broth). Fifteen milliliters was
removed for DNA extraction (in vitro pool). Fifty microliters was used to inoc-
ulate mice intranasally; after 32 h, the mice were sacrificed and their lungs were
removed and homogenized. The recovered bacteria (in vivo pool) were plated by
serial dilutions. The bacteria recovered (approximately 50,000 CFU from each
mouse) were pooled and grown in a flask, and then the genomic DNA was ex-
tracted. The tags of the in vitro and in vivo pools were amplified and labeled with
[32P]dCTP. Variable regions were recovered by HindIII digestion and used to
probe twin filters; DNA tags that hybridize to the family of probes from the in
vitro pool but not from the in vivo pool correspond to mutants negatively selected
in vivo.
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Interestingly, the mutants having insertions in the previously
identified virulence factors (with the exception of SPN-227 and
SPN-1810) did not show reduction in virulence in this animal
model. In contrast, most of the mutants in genes involved in
metabolic functions, transport, and DNA modification showed
a significant reduction in virulence.
DISCUSSION
Characterization of microbial genes that are specifically re-
quired for the establishment and maintenance of an infection
is an important aspect of understanding the mechanism by
which microbial pathogens cause diseases. Large-scale isola-
tion of virulence genes has been performed by either the IVET
(38, 39) or STM (15, 28, 42) method.
The approach that we used to identify new virulence genes
in S. pneumoniae was validated by the fact that among the
mutants unable to survive in mice, insertions were found in
previously identified or predicted pneumococcal virulence
FIG. 4. Identification of avirulent mutants. Two identical filters containing
the same amount of individually amplified DNA tags (from A1 to L5) were
hybridized to labeled DNA tags from the in vitro pool and the in vivo pool. The
filters shown exemplify the many analyzed. Tags that weakly hybridized to the
probes from both the in vitro pool and the in vivo pool (D1, E1, F1, G1, D2, C5,
and E3) probably corresponded to slow-growing mutants and were not consid-
ered. Tags that hybridized to the probe from the in vitro pool but not to the probe
from the in vivo pool (I5, L5, F5, L1, A2, and C4) corresponded to mutants with
attenuated virulence and therefore were unable to survive in the host.
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genes (Table 1). There are contradictory reports about the role
of autolysin in virulence; some authors reported that autolysin-
negative mutants were less virulent than the parent strain (4),
while others claimed that autolysin played no role (56). Our
first screen demonstrates the importance of autolysin for es-
tablishing pneumonia, while intraperitoneal inoculation of the
same mutant shows that it is not necessary for septicemia. The
discrepancies between the published data and ours could be
due to differences in the genetic methodologies. The role of
neuraminidase in streptococcal pathogenesis has been inferred
from immunization studies showing that the purified protein
partially protected mice against pneumococcal infection (36).
A hypothetical role of hyaluronidase in virulence has been
suggested since this enzyme hydrolyzes hyaluronic acid, an
important component of connective tissue (5). Our results are
the first genetic evidence that these genes play an important
role during pneumonia infection. No significant reduction in
virulence was observed when mutants SPN-605, SPN-673, and
SPN-1264 were analyzed in a mouse septicemia model. In this
model, the adhesion and colonization steps are not required
since bacteria are introduced directly in the bloodstream. It is
thus likely that these genes are involved in steps specific for
pneumonia infection. We did not find in our screen genes
involved in capsule biosynthesis. The mutagenesis that we per-
formed was not saturating since we screened only 1,250 inser-
tional mutants. However, we were surprised not to find at least
one mutant mapping in the 20-kb-long capsule cassette.
Neither the pneumolysin gene nor a pneumolysin homo-
logue which can be identified by sequence homology in the
genome (this gene might code for a second hemolysin recently
identified in S. pneumoniae [13]) was found in our screen. This
could be due to the fact that mutants deficient in virulence
proteins acting extracellularly such as the hemolysins might not
be detected by this methodology since they will be comple-
mented by the other strains in the pool.
We found a CBP whose inactivation (SPN-227) resulted in
TABLE 2. Hypothetical genes with unknown function identified by STM
Strain Genea Similar to
b
(source and/or product)
% Amino acid identity
(homology) Notes, Prosite motif(s) Septicemia
c
SPN-1031 yejD (Escherichia coli) 40 (63) Unknown function
Motif: PS01149, hypothetical YciL/YejD/YjbC
family signature
High
SPN-1101 ykrA (Bacillus subtilis) 40 (57) Unknown function Medium
SPN-1119 PHBQ002 (Pyrococcus horikoshii) 30 (48) Unknown function High
SPN-113 TPTC (Streptococcus crista, ABC protein) 34 (59) Hypothetical ABC transporter
Motifs: PS00017, ATP/GTP binding site motif A
(P-loop); PS00211, ABC transporter family
signature
High
SPN-1145 MTCY21C12.02 (Mycobacterium tuberculosis,
putative cation-transporting ATPase)
34 (54) Hypothetical cation-transporting ATPase
Motif: PS00154, E1-E2 ATPase phosphorylation
site
High
SPN-1200 Dictyostelium discoideum a-L-fucosidase precursor 26 (49) Unknown function High
SPN-1338 No homology Unknown function
Motif: PS00343, gram-positive coccus surface
protein-anchoring hexapeptide
Medium
SPN-1471 iga (Streptococcus sanguis) 40 (60) Hypothetical IgA1 protease (different from the
IgA1 protease identified in Streptococcus
pneumoniae) Motif: PS00142 zinc protease
High
SPN-1583 yqeT (B. subtilis, probable methyltransferase) 42 (59) Unknown function Medium
SPN-162 No homology Unknown function Low
SPN-1631 ydeG (Schizosaccharomyces pombe) Unknown function High
SPN-1808 BB0831 (Borrelia burgdorferi, xylose operon
regulatory protein)
30 (49) Unknown function High
SPN-1818 ydhP (B. subtilis) 58 (75) Hypothetical b-glucosidase
Motifs: PS00548, ribosomal protein S3 signature
1; PS00449, ATPase A signature
ND
SPN-224 yidA (E. coli) 48 (69) Unknown function High
SPN-627 ydiL (B. subtilis) 31 (64) Unknown function High
SPN-631 ypsA (B. subtilis) 39 (56) Unknown function High
SPN-633 ypoA Unknown function High
SPN-636 radA (B. subtilis, possible DNA repair protein) 65 (82) Hypothetical DNA repair protein (by homology) ND
Motif: PS00017, ATP/GTP binding site motif A
(P-loop)
SPN-655 ORF8 (Enterococcus faecalis) 45 (63) Unknown function Medium
SPN-233 ybhL (E. coli, hypothetical membrane protein) 41 (60) Unknown function High
SPN-634 No homology The insertion is located in an intergenic region
close to regulatory sequences BoxA and BoxB
High
SPN-641 yitS (B. subtilis) 27 (48) Unknown function Medium
SPN-962 N5,N10-Methylenetetrahydromethanopterin
reductase gene (Staphylococcus carnosus)
54 (75) Hypothetical N5,N10-methyltetrahydromethano-
terin reductase (by homology)
High
SPN-1297 pstB (Methanococcus jannaschii, hypothetical
ABC transporter)
58 (80) Hypothetical ABC transporter (by homology) High
Motifs: PS00017, ATP/GTP binding site motif A
(P-loop); PS00211 ABC transporter family
signature
a Gene already identified in S. pneumoniae.
b Determined obtained by comparison of sequences and coding regions with the EMBL, GenBank DNA and SWISS-PROT databases. BLAST, BLASTX, and
FASTA network services were used.
c For definitions of high, medium, and low, see Materials and Methods. ND, not determined.
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virulence attenuation in both pneumonia and septicemia mod-
els. LytA and PspA are the best-characterized CBPs: LytA is
the major cell wall amidase and is required for cell autolysis
(50); PspA has been characterized as a protective antigen,
although its function is unknown (60, 61). Additional CBPs
have been identified recently in S. pneumoniae (25, 52): SpsA
described by Hammerschmidt et al. (25), CbpA described by
Rosenow et al. (52), and PcpA (GenBank accession no. Z82001)
identified by A. Sanchez-Beato, and J. Garcia. From genomic
analysis, we know that our CBP is different from the above-
mentioned genes that map at other loci on the G54 chromo-
some.
From our in vivo screen, we identified a mutant (SPN-1810)
with an insertion in the IgA1 protease; this enzyme belongs to
the class of extracellular endopeptidases which specifically
cleave human (52) but not mouse (48) IgA1. It has recently
been found that in Neisseria gonorrhoeae, IgA1 protease is
important for survival of this pathogen within epithelial cells
due to its ability to cleave LAMP1, a major integral membrane
protein of lysosomes (35). Since inactivation of IgA1 leads to
reduced virulence in a mouse model, we suggest that IgA1
protease in S. pneumoniae may play a role in pathogenesis by
cleaving some substrate(s) other than immunoglobulins. Fur-
ther support for this hypothesis comes from the fact that SPN-
1810 has attenuated virulence in both pneumonia and sep-
ticemia models; thus, the IgA1 protease could play roles in
addition to counteracting the mucosal defenses (a specific
step in pneumonia infection). Alternatively, the phenotype ob-
served could be ascribed to a polar effect on the expression of
downstream genes. From our genome analysis, it was possible
to identify only one downstream open reading frame (ORF)
since our contig ends with this ORF. Surprisingly, this ORF
codes for a gene showing homology to S. pneumoniae iga (29%
identity and 49% similarity). This iga-like ORF belongs to the
same operon as iga, and we cannot tell if there are termination
signals downstream. This gene, the one identified by STM (mu-
tant SPN-1471 [Table 2], and iga (59) constitute a family of iga-
like genes stressing the importance of its function for S. pneu-
moniae.
The ability to adapt to the host environment is a key com-
ponent of pathogenicity. Many genes whose products are in-
volved in metabolic pathways and nutrient uptake have indeed
been identified following our negative in vivo selection. De novo
synthesis of purines has been shown to be a strict requirement
for bacterial growth and persistence under the nucleotide-limit-
ing conditions in the host (38); also purine auxotrophy atten-
uates many pathogenic bacteria (58). Accordingly, insertions in
four genes belonging to the purine biosynthetic pathway (purE,
purK, purC, and purL) were found. Three insertions in genes
involved in glutamine metabolism, glnA (glutamine synthase),
glnQ, and glnH (high-affinity glutamine transport system), were
identified, suggesting that reduced availability of glutamine
synthesis or loss of high-affinity glutamine transport leads to
virulence attenuation in S. pneumoniae. Klose and Mekalanos
(34) reported that only the simultaneous inactivation of glu-
tamine synthesis (glnA) and high-affinity transport (glnH) re-
duced virulence in S. typhimurium. Since salmonellae also have
a low-affinity glutamine transport system, a mutant defective in
both glnA and glnH can survive in vitro when supplemented
with a high level of glutamine but not in vivo due to the low
level of this metabolite in animal tissues. Glutamine is a key
metabolite since it is the major donor of amino groups in the
amino acid biosynthetic pathway and it is required in the first
two steps of purine biosynthesis. The virulence defects of
S. pneumoniae support the hypothesis that the concentration of
glutamine in the host is a critical parameter for in vivo survival
and show that import and biosynthesis are both required in vivo.
Nutrient and amino acid uptake seems to be a critical factor
for in vivo survival of S. pneumoniae. Two mutants unable to
grow in mice had insertions in potA and potD, which encode
the ATPase component and substrate binding lipoprotein, re-
spectively, of the spermidine/putrescine ABC transport system.
Spermidine and putrescine are polyamines whose synthesis uses
arginine as a precursor. A mutant in arginine transport in
L. monocytogenes (33) and more recently a mutant in arginine
biosynthesis in V. cholerae (11) were both shown to be atten-
uated in virulence. One mutant (SPN-1802) had an insertion in
a gene with strong homology to msmK, a component of a
multiple-sugar uptake system of S. mutans (53). S. pneumoniae
is limited in sugar fermentation ability, being able to use only
glucose, raffinose, lactose, threalose, and maltose as sources of
energy (30, 44). The MsmK homologue in S. pneumoniae is
likely to play a role in the transport of those sugars.
One gene involved in anaerobic metabolism, adh (encoding
alcohol dehydrogenase) was identified in this study. S. pneu-
moniae is a facultative anaerobe, and its energy-yielding me-
tabolism is fermentative. Alcohol dehydrogenase catalyzes the
reduction of acetyl coenzyme A first to acetaldehyde and then
to ethanol. These reactions are needed to regenerate reducing
ability (NADH) from glycolysis under anaerobic conditions.
Our data suggest that as infection progresses, streptococci must
adapt to low-oxygen tension environments, and a fully active
anaerobic metabolism is required for survival in the host.
One insertion (SPN-1055) maps in a gene whose product
shows similarity to ClpC, one of the regulatory subunits of Clp
proteases. Clp proteases are a family of highly conserved pro-
teins involved in ATP-dependent proteolysis (23). The Clp
protease in E. coli is a two-component system where the larger
regulatory subunit (ClpA, ClpB, or ClpX) has ATPase activity
and the smaller subunit (ClpP) has proteolytic activity. The Clp
protease is involved not only in degradation of toxic denatured
proteins but also in controlling the half-life of unstable pro-
teins to modulate gene expression. In fact, Clp proteases have
been shown to be important in modulation of stress response,
stationary phase, and competence in B. subtilis (41). Recent
evidence suggests that Clp proteases also may be involved in
modulating virulence. A ClpP homologue has been shown to
be essential for survival of S. typhimurium in the spleen (28),
the regulatory subunit ClpC is required for survival of L. mono-
cytogenes in macrophages (51), and more recently a ClpX ho-
mologue has been found to be important for virulence in S. au-
reus (42). It is not clear what role is played by these Clp
proteins in the virulence process or what pathways are affected,
but it is tempting to suggest a common mechanism of action.
Identification of the gene products that are regulated by the
S. pneumoniae ClpC homologue will shed light on the role of
this regulatory protein in virulence.
The ability to keep spontaneous mutation levels low seems
to be crucial for in vivo survival. A mutant (SPN-1634) showing
insertions in the S. pneumoniae mutX gene (the homologue of
E. coli mutT) (43) and a mutant (SPN-1411) whose insertion
maps in a gene similar to recJ were identified. MutX is an
NTPase whose role is to hydrolyze 8-oxo-dGTP to 8-oxo-
dGMP, thus preventing its incorporation into DNA (21, 43).
RecJ is a single-stranded DNA binding protein involved in
DNA recombination/repair (37). It is known that during infec-
tion, pathogenic bacteria may encounter a variety of oxygen
radicals produced by macrophages and neutrophils. These ox-
ygen species are likely to induce mutations in the DNA or to
oxidize the NTP pool. The ability to repair DNA damage has
indeed been shown to be essential for full S. typhimurium (27)
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and S. aureus (42) virulence. The recombination-deficient recA
and recBC mutants of S. typhimurium have been shown to be
sensitive to the oxidizing compounds generated by the oxida-
tive burst of macrophages or phagocytes (9, 27).
The results presented in this paper clearly show that S. pneu-
moniae virulence is a multifactorial process and that, in addi-
tion to factors involved in specific steps in pneumonia infec-
tion, many other gene products are required to confer to the
bacterial cells the ability to grow and survive in the host. Most
of the mutants isolated that bore genes involved in metabolic
functions, transport, and DNA modification showed reduction
in virulence in both the pneumonia and septicemia models.
This finding is consistent with the hypothesis that these func-
tions are needed for bacterial adaptation to the different host
environments and not for specific steps during infection. The
adaptation of IVET and STM technologies to several distinct
bacterial pathogens is revealing that different pathogens caus-
ing different diseases may have virulence determinants in com-
mon. Indeed, many of the genes identified in this work as
important for S. pneumoniae survival in the host were also
identified as virulence determinants in other pathogens
(S. typhimurium, S. aureus, V. cholerae, and P. aeruginosa).
Insertions in several genes that show no homology to known
genes in databases or that have similarity to hypothetical pro-
teins could potentially encode novel factors that may play im-
portant roles in the bacterial infection process. The identi-
fication of the entire ORF and search for specific motifs or
domains may give clues about the putative function of these
proteins.
Despite the possibility that some of our mutants show polar
effects, our data provide strong evidence that the ability to
sense and respond to complex and overlapping signals encoun-
tered in the host is a key point in pathogenicity. This ability
results in the elaboration of regulatory, metabolic, and viru-
lence functions that contribute to growth and persistence in the
host. We are currently constructing nonpolar mutations to
exclude the involvement of neighboring genes in virulence. We
believe that the approach described here can serve as a basis
for a more comprehensive understanding of S. pneumoniae
pathogenicity.
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